# Pursuit Attractions & Hospitality, Inc.: financial statements, quarterly

PRSU · NYSE · CIK 884219 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prsu.md) · [Financials](/companies/prsu/financials.md) · [Filings](/companies/prsu/filings.md) · [Insiders](/companies/prsu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/prsu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [366](/filings/0000950170-24-123522.md) | [(597) d](/filings/0001193125-26-071582.md) | [37.2](/filings/0000950170-25-068127.md) | [101](/filings/0000950170-25-104958.md) | [182](/filings/0001193125-25-269463.md) | [45.8 d](/filings/0001193125-26-071582.md) | [37.6](/filings/0001193125-26-208981.md) | [117](/filings/0001193125-26-335133.md) | [241](/filings/0001193125-25-269463.md) | [57.1 d](/filings/0001193125-26-071582.md) | [51.6](/filings/0001193125-26-208981.md) | [133](/filings/0001193125-26-335133.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | [17.0](/filings/0001193125-25-269463.md) | [3.2 d](/filings/0001193125-26-071582.md) | [2.3](/filings/0001193125-26-208981.md) | [8.9](/filings/0001193125-26-335133.md) | [19.8](/filings/0001193125-25-269463.md) | [3.7 d](/filings/0001193125-26-071582.md) | [3.0](/filings/0001193125-26-208981.md) | [9.6](/filings/0001193125-26-335133.md) |
| Selling, general and administrative | $m | not reported | not reported | [12.8](/filings/0000950170-25-068127.md) | [13.7](/filings/0000950170-25-104958.md) | [14.5](/filings/0001193125-25-269463.md) | [16.7 d](/filings/0001193125-26-071582.md) | [20.7](/filings/0001193125-26-208981.md) | [19.6](/filings/0001193125-26-335133.md) | [17.4](/filings/0001193125-25-269463.md) | [29.8 d](/filings/0001193125-26-071582.md) | [19.2](/filings/0001193125-26-208981.md) | [20.8](/filings/0001193125-26-335133.md) |
| Operating income | $m | [76.0](/filings/0000950170-24-123522.md) | [4.5 d](/filings/0000950170-24-023724.md) | [(8.5)](/filings/0000950170-24-052502.md) | [53.4](/filings/0000950170-24-092988.md) | [92.5](/filings/0000950170-24-123522.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [12.5](/filings/0000950170-24-123522.md) | [(31.1) d](/filings/0001193125-26-071582.md) | [2.9](/filings/0000950170-25-068127.md) | [3.9](/filings/0000950170-25-104958.md) | [3.5](/filings/0001193125-25-269463.md) | [3.9 d](/filings/0001193125-26-071582.md) | [1.5](/filings/0001193125-26-208981.md) | [1.9](/filings/0001193125-26-335133.md) | [2.8](/filings/0001193125-25-269463.md) | [2.6 d](/filings/0001193125-26-071582.md) | [2.7](/filings/0001193125-26-208981.md) | [3.2](/filings/0001193125-26-335133.md) |
| Income tax | $m | [9.2](/filings/0000950170-24-123522.md) | [(0.7) d](/filings/0001193125-26-071582.md) | [(1.7)](/filings/0000950170-25-068127.md) | [2.8](/filings/0000950170-25-104958.md) | [10.5](/filings/0001193125-25-269463.md) | [(5.3) d](/filings/0001193125-26-071582.md) | [(1.9)](/filings/0001193125-26-208981.md) | [3.0](/filings/0001193125-26-335133.md) | [17.8](/filings/0001193125-25-269463.md) | [(2.4) d](/filings/0001193125-26-071582.md) | [(1.2)](/filings/0001193125-26-208981.md) | [4.2](/filings/0001193125-26-335133.md) |
| Net income | $m | [41.3](/filings/0000950170-24-123522.md) | [(15.3) d](/filings/0001193125-26-071582.md) | [(25.1)](/filings/0000950170-25-068127.md) | [29.3](/filings/0000950170-25-104958.md) | [48.6](/filings/0001193125-25-269463.md) | [316 d](/filings/0001193125-26-071582.md) | [(31.1)](/filings/0001193125-26-208981.md) | [5.6](/filings/0001193125-26-335133.md) | [73.9](/filings/0001193125-25-269463.md) | [(25.7) d](/filings/0001193125-26-071582.md) | [(24.9)](/filings/0001193125-26-208981.md) | [15.2](/filings/0001193125-26-335133.md) |
| Diluted EPS | $ per share | [1.41](/filings/0000950170-24-123522.md) | not reported | [(1.29)](/filings/0000950170-25-068127.md) | [0.98](/filings/0000950170-25-104958.md) | [1.65](/filings/0001193125-25-269463.md) | not reported | [(1.11)](/filings/0001193125-26-208981.md) | [0.20](/filings/0001193125-26-335133.md) | [2.60](/filings/0001193125-25-269463.md) | not reported | [(0.90)](/filings/0001193125-26-208981.md) | [0.54](/filings/0001193125-26-335133.md) |
| Basic EPS | $ per share | [1.43](/filings/0000950170-24-123522.md) | not reported | [(1.29)](/filings/0000950170-25-068127.md) | [0.98](/filings/0000950170-25-104958.md) | [1.68](/filings/0001193125-25-269463.md) | not reported | [(1.11)](/filings/0001193125-26-208981.md) | [0.20](/filings/0001193125-26-335133.md) | [2.61](/filings/0001193125-25-269463.md) | not reported | [(0.90)](/filings/0001193125-26-208981.md) | [0.55](/filings/0001193125-26-335133.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [106](/filings/0000950170-23-058776.md) | [27.4](/filings/0000950170-25-040127.md) | [48.8](/filings/0000950170-24-052502.md) | [59.4](/filings/0000950170-24-092988.md) | [64.6](/filings/0000950170-24-123522.md) | [49.7](/filings/0001193125-26-071582.md) | [22.8](/filings/0001193125-26-208981.md) | [24.7](/filings/0001193125-26-335133.md) | [33.8](/filings/0001193125-25-269463.md) | [31.1](/filings/0001193125-26-335133.md) | [34.5](/filings/0001193125-26-208981.md) | [33.9](/filings/0001193125-26-335133.md) |
| Current assets | $m | [318](/filings/0000950170-23-058776.md) | [236](/filings/0000950170-25-040127.md) | [284](/filings/0000950170-24-052502.md) | [331](/filings/0000950170-24-092988.md) | [310](/filings/0000950170-24-123522.md) | [117](/filings/0001193125-26-071582.md) | [100](/filings/0001193125-26-208981.md) | [120](/filings/0001193125-26-335133.md) | [114](/filings/0001193125-25-269463.md) | [63.7](/filings/0001193125-26-335133.md) | [205](/filings/0001193125-26-208981.md) | [217](/filings/0001193125-26-335133.md) |
| Total assets | $m | [1,201](/filings/0000950170-23-058776.md) | [1,137](/filings/0000950170-25-040127.md) | [1,180](/filings/0000950170-24-052502.md) | [1,223](/filings/0000950170-24-092988.md) | [1,196](/filings/0000950170-24-123522.md) | [845](/filings/0001193125-26-071582.md) | [833](/filings/0001193125-26-208981.md) | [893](/filings/0001193125-26-335133.md) | [997](/filings/0001193125-25-269463.md) | [965](/filings/0001193125-26-335133.md) | [1,005](/filings/0001193125-26-208981.md) | [1,020](/filings/0001193125-26-335133.md) |
| Current liabilities | $m | [267](/filings/0000950170-23-058776.md) | [233](/filings/0000950170-25-040127.md) | [292](/filings/0000950170-24-052502.md) | [309](/filings/0000950170-24-092988.md) | [308](/filings/0000950170-24-123522.md) | [76.4](/filings/0001193125-26-071582.md) | [91.7](/filings/0001193125-26-208981.md) | [116](/filings/0001193125-26-335133.md) | [105](/filings/0001193125-25-269463.md) | [78.8](/filings/0001193125-26-335133.md) | [134](/filings/0001193125-26-208981.md) | [135](/filings/0001193125-26-335133.md) |
| Total liabilities | $m | [922](/filings/0000950170-23-058776.md) | [867](/filings/0000950170-25-040127.md) | [944](/filings/0000950170-24-052502.md) | [961](/filings/0000950170-24-092988.md) | [869](/filings/0000950170-24-123522.md) | [228](/filings/0001193125-26-071582.md) | [243](/filings/0001193125-26-208981.md) | [271](/filings/0001193125-26-335133.md) | [308](/filings/0001193125-25-269463.md) | [305](/filings/0001193125-26-335133.md) | [393](/filings/0001193125-26-208981.md) | [411](/filings/0001193125-26-335133.md) |
| Long-term debt | $m | [405](/filings/0000950170-23-058776.md) | [389](/filings/0000950170-25-040127.md) | [407](/filings/0000950170-24-052502.md) | [414](/filings/0000950170-24-092988.md) | [326](/filings/0000950170-24-123522.md) | [15.0](/filings/0001193125-26-071582.md) | [19.9](/filings/0001193125-26-208981.md) | [26.8](/filings/0001193125-26-335133.md) | [66.6](/filings/0001193125-25-269463.md) | [99.3](/filings/0001193125-26-335133.md) | [177](/filings/0001193125-26-208981.md) | [192](/filings/0001193125-26-335133.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [51.8](/filings/0000950170-23-058776.md) | [43.4](/filings/0000950170-25-040127.md) | [12.2](/filings/0000950170-24-052502.md) | [41.2](/filings/0000950170-24-092988.md) | [96.8](/filings/0000950170-24-123522.md) | [526](/filings/0001193125-26-071582.md) | [498](/filings/0001193125-26-208981.md) | [528](/filings/0001193125-26-335133.md) | [607](/filings/0001193125-25-269463.md) | [582](/filings/0001193125-26-335133.md) | [534](/filings/0001193125-26-208981.md) | [536](/filings/0001193125-26-335133.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [77.8 d](/filings/0000950170-24-123522.md) | [(11.9) d](/filings/0000950170-24-023724.md) | [(7.5)](/filings/0000950170-24-052502.md) | [30.3 d](/filings/0000950170-24-092988.md) | [110 d](/filings/0000950170-24-123522.md) | [(76.1) d](/filings/0001193125-26-071582.md) | [(24.4)](/filings/0001193125-26-208981.md) | [21.6 d](/filings/0001193125-26-335133.md) | [103 d](/filings/0001193125-25-269463.md) | [(13.6) d](/filings/0001193125-26-071582.md) | [(29.5)](/filings/0001193125-26-208981.md) | [18.5 d](/filings/0001193125-26-335133.md) |
| Capital expenditure | $m | [22.5](/filings/0000950170-24-123522.md) | [7.7 d](/filings/0001193125-26-071582.md) | [16.4](/filings/0000950170-25-068127.md) | [17.1](/filings/0000950170-24-092988.md) | [14.9](/filings/0000950170-24-123522.md) | [15.6 d](/filings/0001193125-26-071582.md) | [9.9](/filings/0001193125-26-208981.md) | [18.4 d](/filings/0001193125-26-335133.md) | [15.8 d](/filings/0001193125-25-269463.md) | [30.9 d](/filings/0001193125-26-071582.md) | [16.9](/filings/0001193125-26-208981.md) | [19.7 d](/filings/0001193125-26-335133.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-208981.md) | [0.0 d](/filings/0001193125-26-335133.md) | not reported | not reported | [25.2](/filings/0001193125-26-208981.md) | [7.5 d](/filings/0001193125-26-335133.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.9](/filings/0000950170-23-058776.md) | [20.8](/filings/0000950170-24-052502.md) | [21.0](/filings/0000950170-24-092988.md) | [21.2](/filings/0000950170-24-123522.md) | [21.0](/filings/0000950170-25-068127.md) | [21.1](/filings/0000950170-25-104958.md) | [21.6](/filings/0001193125-25-269463.md) | [28.1](/filings/0001193125-26-208981.md) | [28.4](/filings/0001193125-26-335133.md) | [28.5](/filings/0001193125-25-269463.md) | [27.9](/filings/0001193125-26-208981.md) | [28.0](/filings/0001193125-26-335133.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,264,155 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335133.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.